MMDI (Minnesota Medical Development) hernia repair tech:
This article was originally published in Clinica
Executive Summary
Minnesota Medical Development (MMDI) has CE-marked for sale in Europe its Rebound HRD hernia repair device. The product is a self-expanding nitinol framed/surgical mesh device for the laparoscopic repair of inguinal and ventral hernias. After being folded and inserted laparoscopically, the device fully unfurls or "rebounds" back to its original shape - ready for quick and easy placement over the hernia defect. It conforms to the anatomy while providing stability; eliminating the need for anchoring, which in turn, minimises patient post-op discomfort and the risk of nerve/blood vessel injury, said the Plymouth, Minnesota firm. The device is currently pending US FDA 510(k) approval.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.